Cargando…
Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?
Neurodegenerative diseases are often misdiagnosed, especially when the diagnosis is based solely on clinical symptoms. The p75 neurotrophic receptor (p75(NTR)) has been studied as an index of sensory and motor nerve development and maturation. Its cleavable extracellular domain (ECD) is readily dete...
Autores principales: | Jourdi, Georges, Fleury, Samuel, Boukhatem, Imane, Lordkipanidzé, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581574/ https://www.ncbi.nlm.nih.gov/pubmed/37721281 http://dx.doi.org/10.4103/1673-5374.380873 |
Ejemplares similares
-
Tissue-Specificity of Antibodies Raised Against TrkB and p75(NTR) Receptors; Implications for Platelets as Models of Neurodegenerative Diseases
por: Fleury, Samuel, et al.
Publicado: (2021) -
Platelets Selectively Regulate the Release of BDNF, But Not That of Its Precursor Protein, proBDNF
por: Le Blanc, Jessica, et al.
Publicado: (2020) -
Clinical Correlates Identify ProBDNF and Thrombo-Inflammatory Markers as Key Predictors of Circulating p75(NTR) Extracellular Domain Levels in Older Adults
por: Fleury, Samuel, et al.
Publicado: (2022) -
Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
por: Jourdi, Georges, et al.
Publicado: (2022) -
Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
por: Jourdi, Georges, et al.
Publicado: (2021)